Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/20/2026 | CALL | $120.00 | 78 | +78 | |
| 01/16/2026 | CALL | $110.00 | 258 | +19 | +7.95% |
| 02/20/2026 | CALL | $135.00 | 18 | +18 | |
| 02/20/2026 | PUT | $100.00 | 8 | +8 | |
| 12/19/2025 | PUT | $110.00 | 13 | +2 | +18.18% |
| 02/20/2026 | CALL | $100.00 | 1 | +1 | |
| 12/18/2026 | PUT | $155.00 | 0 | 0 | |
| 12/18/2026 | PUT | $160.00 | 0 | 0 | |
| 12/18/2026 | PUT | $165.00 | 0 | 0 | |
| 12/18/2026 | PUT | $170.00 | 0 | 0 | |
| 12/19/2025 | CALL | $115.00 | 30 | -1 | -3.23% |
| 12/19/2025 | CALL | $100.00 | 130 | -100 | -43.48% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| iShares Core S&P Smallcap ETF | 7.54% | 3.61M | 259.96M |
| Brown Capital Management Small Company Fund | 3.46% | 1.65M | 119.09M |
| Vanguard Explorer Fund, Inc. | 3.16% | 1.51M | 108.97M |
| Vanguard Total Stock Market Index Fund | 2.88% | 1.38M | 99.16M |
| Artisan International Small-Mid Fund | 2.49% | 1.19M | 85.97M |
| Vanguard Small-Cap Index Fund | 2.44% | 1.17M | 84.02M |
| Janus Henderson Triton Fund | 2.17% | 1.04M | 74.86M |
| iShares Russell 2000 ETF | 2.10% | 1.01M | 72.35M |
| Vanguard Specialized-Health Care Fund | 1.95% | 934.75k | 67.27M |
| Smallcap World Fund | 1.57% | 750.32k | 54M |
Nicox prévoit de rembourser intégralement ses dettes financières, NCX 470 ayant été dé-risqué et licencié dans le monde entier
09/04 01:30 am
GlobeNewswire Inc.
Read moreNicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed
09/04 01:30 am
GlobeNewswire Inc.
Read moreGlaukos Stocks Rides on Strong Product Demand Amid Competition
09/11 02:20 pm
Benzinga
Read moreWill WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings? - Zacks Investment Research
07/16 10:30 am
Zacks Investment Research
Read moreThis Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
07/10 09:05 am
Benzinga
Read moreGlobal Ophthalmic Devices Market Analysis Report 2024-2032 Featuring Johnson & Johnson, Topcon, Canon, Alcon ... - GlobeNewswire
07/04 06:07 am
GlobeNewswire Inc.
Read moreGlaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?
06/27 12:49 pm
Zacks Investment Research
Read moreGlaukos (GKOS) Stock Jumps 3.7%: Will It Continue to Soar?
06/27 03:19 am
Zacks Investment Research
Read moreWhy Is Waters (WAT) Down 5.1% Since Last Earnings Report?
06/06 11:31 am
Zacks Investment Research
Read moreGlaukos (GKOS) Gains 40.4% YTD: What's Driving the Rally?
06/05 12:14 pm
Zacks Investment Research
Read moreHere's Why You Should Retain Glaukos (GKOS) Stock for Now
06/03 01:53 pm
Zacks Investment Research
Read moreGlaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
05/14 12:20 pm
Zacks Investment Research
Read moreEye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
05/02 03:36 pm
Benzinga
Read moreGlaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y
05/02 09:14 am
Zacks Investment Research
Read moreGlaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates
05/01 05:50 pm
Zacks Investment Research
Read moreCan the 4 Medical Device Stocks Hit Targets This Earnings Season?
04/30 10:20 am
Zacks Investment Research
Read moreHere's Why You Should Retain Glaukos (GKOS) Stock for Now
04/15 08:19 am
Zacks Investment Research
Read moreGlaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?
04/12 09:22 am
Zacks Investment Research
Read moreAnalyst Ratings For Glaukos
04/08 12:00 pm
Benzinga
Read moreGlaukos (GKOS) Hits 52-Week High: What's Driving the Stock?
04/08 10:41 am
Zacks Investment Research
Read moreGlaukos' (GKOS) iDose TR Receives Permanent J- Code From CMS
04/04 12:02 pm
Zacks Investment Research
Read moreSignet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
04/03 10:31 am
Benzinga
Read more5 Analysts Have This To Say About Glaukos
03/22 03:01 pm
Benzinga
Read moreGlaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound?
03/22 11:30 am
Zacks Investment Research
Read moreHere's Why You Should Retain Glaukos (GKOS) Stock for Now
03/13 07:56 am
Zacks Investment Research
Read moreGlaukos (GKOS) Q4 Earnings Miss Estimates, Revenues Rise Y/Y
02/22 09:58 am
Zacks Investment Research
Read moreAnalog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
02/22 08:23 am
Benzinga
Read moreGlaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates
02/21 06:20 pm
Zacks Investment Research
Read moreTactile Systems Technology (TCMD) Beats Q4 Earnings Estimates
02/20 09:40 am
Zacks Investment Research
Read moreAnalyst Ratings For Glaukos
02/16 08:00 am
Benzinga
Read morePenumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
02/15 11:00 am
Zacks Investment Research
Read moreGlaukos (GKOS) Expected to Beat Earnings Estimates: Should You Buy?
02/14 11:00 am
Zacks Investment Research
Read moreHere's Why You Should Retain Glaukos (GKOS) Stock for Now
02/14 09:15 am
Zacks Investment Research
Read moreThe Zacks Analyst Blog Highlights Globus Medical, Glaukos, PROCEPT, Edwards Lifesciences and Quest Diagnostics
02/14 07:00 am
Zacks Investment Research
Read moreWhat's in Store for West Pharmaceutical (WST) in Q4 Earnings?
02/13 09:57 am
Zacks Investment Research
Read more3 Medtech Stocks Likely to Top Estimates This Earnings Season
02/13 08:49 am
Zacks Investment Research
Read moreGlaukos (GKOS) Hits 52-Week High: What's Driving the Stock?
01/30 11:42 am
Zacks Investment Research
Read moreHere's Why You Should Retain Glaukos (GKOS) Stock for Now
01/16 08:41 am
Zacks Investment Research
Read moreGlaukos' (GKOS) Preliminary Q4 Revenues Ride on Product Demand
01/11 12:26 pm
Zacks Investment Research
Read moreGlaukos' Newly Approved Glaucoma Treatment Is The 'Biggest Driver To Watch': Analyst
12/21 12:48 pm
Benzinga
Read moreAmazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
12/21 08:36 am
Benzinga
Read moreUnveiling 7 Analyst Insights On Glaukos
12/21 08:00 am
Benzinga
Read moreGlaukos' (GKOS) iDose TR Gets FDA Nod for Glaucoma Treatment
12/19 02:28 pm
Zacks Investment Research
Read moreGlaukos (GKOS) Hits 52-Week High: What's Aiding the Stock?
12/18 10:49 am
Zacks Investment Research
Read moreiDoseTR Approval Sets Stage for Glaukos' Game-Changing Product, Surpassing Market Expectations, Says Analyst
12/15 02:49 pm
Benzinga
Read moreHere's Why You Should Retain Glaukos (GKOS) Stock for Now
12/14 08:45 am
Zacks Investment Research
Read moreWhy Is Glaukos (GKOS) Down 0.4% Since Last Earnings Report?
12/01 12:31 pm
Zacks Investment Research
Read moreAnalyst Ratings for Glaukos
11/28 10:00 am
Benzinga
Read moreShould You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
11/23 07:20 am
Zacks Investment Research
Read more